COVID-19 Vaccine and Treatment Strategy
Our COVID-19 Vaccine and Treatment Strategy supports access to, and delivery of, safe and effective COVID-19 vaccines and treatments, as soon as they are available.
About the strategy
The strategy outlines how we are investing in promising vaccines and treatments and how we can provide them to Australians.
Why it is important
The strategy is helping to speed up access to safe and effective vaccines or treatment that are available and affordable to all Australians.
This will reduce the health, social and economic impacts of the COVID-19 pandemic. It will help save lives and livelihoods.
Our goal is early access to, and delivery, of safe and effective COVID-19 vaccines and treatments for all Australians.
To do this, the strategy is focusing on 5 key areas.
Research and development
We are identifying and supporting world-leading research activities to speed up the development and manufacture of promising COVID-19 vaccines and treatments.
Purchase and manufacturing
We are building a diverse global portfolio of investments to seek to secure early access to promising vaccines and treatments. Opportunities to use and strengthen local manufacturing are being sought as part of investment decisions.
We are working with organisations and countries around the world to accelerate development of a safe and effective vaccine and treatments for COVID-19.
It is important that access to vaccines and treatments is available and affordable to all people. To help achieve this, we are working closely with our neighbours across the Pacific and South East Asia, focusing on immunisation policy and coverage.
Regulation and safety
We will use Therapeutic Goods Administration (TGA) regulatory pathways to enable early access to COVID-19 vaccines and treatments. The TGA will work with international counterparts, sharing information on vaccine clinical trials, manufacturing and safety. This will ensure a safe and fast regulatory process for Australia and our region.
Immunisation administration and monitoring
Australians will receive safe and effective vaccines under a targeted and responsive national COVID-19 vaccination policy and immunisation program. Policies and programs will be based on up-to-date health advice.
Meeting our goals
Researchers and companies across the world are developing potential vaccines for COVID-19. The Australian Government is working closely with developers to track vaccine progress and provide access for Australians if vaccines are successful. Read more in the Prime Minister’s media release.
The Australian Government has agreements for the supply of COVID-19 vaccines, if they are proved to be safe and effective, with:
Read more about the supply production agreements.
Australians now have access to a suite of potential COVID-19 vaccines by joining the international COVAX Facility. Read more about our commitment.
Who we work with
To achieve our goals we are working with:
- the COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group
- the TGA
- the Australian Technical Advisory Group on Immunisation (ATAGI) COVID-19 Working Group
- local and international vaccine manufacturers.
Learn more about:
- how we are preparing for possible vaccines and treatments
- COVID-19 vaccine and treatment strategy
- Australia's vaccine agreements.